4-Amino-1-(1-Boc-pyrrolidin-3-yl)-1H-pyrazole, 97.0%, 1g

ethyl 8-(3,5-difluorophenyl)-8-oxooctanoate, 97.0%, 1g

[(4-tert-butylphenyl)methyl](prop-2-en-1-yl)amine, 95.0%, 10g

1-bromo-2-(methoxymethoxy)benzene, 95.0%, 25g

6-CHLORO-7-(2-FLUOROBENZYL)-7H-PURINE, 90.0%, 250mg

(Difluoromethyl)bis(2,5-dimethylphenyl)sulfonium Tetrafluoroborate>95.0%(qNMR)5g

2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetamide, 95.0%, 1g

(2S,2'S,3S,3'S)-4,4'-Di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97%, 500mg

2-Bromo-4-fluoro-5-methylpyridine, 95.0%, 100mg

4,4'-Bis(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)biphenyl>98.0%(GC)(T)1g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)aniline, 98%, 1g

Mesityl Iodide>98.0%(GC)5g

(1R*,4R*)-N1-(Tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine dihydrochloride, 1g